Jumpei Kawajiri1,2, Kokoro Nagata3, Akiko Nakamura4, Atsushi Fujieda5, Kazuko Ino5, Jouji Nomura3, Naoya Arai3, Kohshi Ohishi6, Naoyuki Katayama1,5, Kazunori Nakase7,8. 1. Faculty of Nursing, Suzuka University of Medical Science, Mie, Japan. 2. Department of Translational Medical Science, Mie University Graduate School of Medicine, Mie, Japan. 3. Department of Oral and Maxillofacial Surgery, Mie University Hospital, Mie, Japan. 4. Central Clinical Laboratories, Mie University Hospital, Mie, Japan. 5. Department of Hematology and Oncology, Mie University Hospital, Mie, Japan. 6. Transfusion Service, Mie University Hospital, Mie, Japan. 7. Department of Hematology and Oncology, Mie University Hospital, Mie, Japan. k2nakase@clin.medic.mie-u.ac.jp. 8. Cancer Center, Mie University Hospital, Mie, Japan. k2nakase@clin.medic.mie-u.ac.jp.
Abstract
PURPOSE: This study aimed to clarify the clinical utility of oral management to prevent bloodstream infections by oral bacteria microbiologically in patients undergoing allogeneic hematopoietic stem cell transplantation (ASCT). METHODS: Ten consecutive patients with hematological malignancies undergoing ASCT were enrolled in this study. We implemented dental treatments before transplantation, if required, and carried out oral hygiene instructions and oral management every other day after transplantation. Molecular analysis of bacterial DNA for seven oral species using a polymerase chain reaction (PCR) assay was performed for oral samples and peripheral blood once a week for 3 weeks after transplantation. RESULTS: Periodontitis was found in all 10 patients (mild grade in 3 and middle grade in 7) for whom basic periodontal therapy was conducted. Necessary dental procedures, including tooth extraction were performed in 5 patients. After transplantation, oral mucositis occurred in 10 patients (grade 1 in 3, grade 2 in 2, and grade 3 in 5) for whom oral hygiene instruction and oral care were continued every other day. PCR-identified three to six bacterial species in oral samples from nine patients, but none in peripheral blood from any patient during the observation period. CONCLUSIONS: Our study suggests that oral management could prevent bloodstream infections by oral bacteria in ASCT recipients despite the existence of periodontitis or oral mucositis. Its utility was confirmed by microbiological evidence based on molecular data.
PURPOSE: This study aimed to clarify the clinical utility of oral management to prevent bloodstream infections by oral bacteria microbiologically in patients undergoing allogeneic hematopoietic stem cell transplantation (ASCT). METHODS: Ten consecutive patients with hematological malignancies undergoing ASCT were enrolled in this study. We implemented dental treatments before transplantation, if required, and carried out oral hygiene instructions and oral management every other day after transplantation. Molecular analysis of bacterial DNA for seven oral species using a polymerase chain reaction (PCR) assay was performed for oral samples and peripheral blood once a week for 3 weeks after transplantation. RESULTS: Periodontitis was found in all 10 patients (mild grade in 3 and middle grade in 7) for whom basic periodontal therapy was conducted. Necessary dental procedures, including tooth extraction were performed in 5 patients. After transplantation, oral mucositis occurred in 10 patients (grade 1 in 3, grade 2 in 2, and grade 3 in 5) for whom oral hygiene instruction and oral care were continued every other day. PCR-identified three to six bacterial species in oral samples from nine patients, but none in peripheral blood from any patient during the observation period. CONCLUSIONS: Our study suggests that oral management could prevent bloodstream infections by oral bacteria in ASCT recipients despite the existence of periodontitis or oral mucositis. Its utility was confirmed by microbiological evidence based on molecular data.
Authors: Joel B Epstein; Judith E Raber-Durlacher; Judith E Raber-Drulacher; Affi Wilkins; Maria-Gabriella Chavarria; Han Myint Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Date: 2009-03
Authors: Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly Journal: Support Care Cancer Date: 2013-01-04 Impact factor: 3.603
Authors: Hafsa M Chaudhry; Alison J Bruce; Robert C Wolf; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Walter K Kremers; Gordon L Phillips; Shahrukh K Hashmi Journal: Biol Blood Marrow Transplant Date: 2015-09-26 Impact factor: 5.742
Authors: Judith E Raber-Durlacher; Joel B Epstein; John Raber; Jaap T van Dissel; Arie Jan van Winkelhoff; Harry F L Guiot; Ubele van der Velden Journal: Support Care Cancer Date: 2002-03-23 Impact factor: 3.603
Authors: Alexa M G A Laheij; Johannes J de Soet; Peter A von dem Borne; Ed J Kuijper; Eefje A Kraneveld; Cor van Loveren; Judith E Raber-Durlacher Journal: Support Care Cancer Date: 2012-04-26 Impact factor: 3.603